Document is current
Any future updates will be listed below
-
Authors
Chappell, Daniel
Jacob, Matthias
- License Information
-
More Information
Article History
Received: 8 January 2026
Accepted: 16 January 2026
First Online: 5 February 2026
Interessenkonflikt
: D. Chappell hat Vortragshonorare erhalten von: AOP Pharma, B. Braun, CSL Behring, Edwards Lifesciences, Fresenius Kabi, Getinge, Grifols, Philips Healthcare, Sintetica, Teva Ratiopharm. M. Jacob hatte in den letzten 3 Jahren keine Interessenkonflikte.
